Theratechnologies Announces Dosing of First Patient in Updat

Theratechnologies Announces Dosing of First Patient in Updated Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer

Theratechnologies Announces Dosing of First Patient in Updated Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer

lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Montreal , Quebec , Canada , American , Julie Schneiderman , Ira Winer , Christian Marsolais , Philippe Dubuc , Sudocetaxel Zendusortide , Karmanos Cancer Center , Drug Administration , Theratechnologies Inc , American Society Of Clinical Oncology , Milestone For Company , Twitter , Linkedin , Communications Corporate Affairs , Announces Dosing , First Patient , Updated Clinical Trial , Advanced Ovarian , Senior Vice President , Chief Medical Officer , Gynecologic Oncology , American Society , Fast Track , Forward Looking Statements , Looking Statements , Annual Information Form , Vice President , Chief Financial ,